SEC Filing Details

SEC Filing Details

Document Details

Form
3
Filing Date
Jan 17, 2019
Document Date
Jan 15, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
ReShape Lifesciences
Issuer
Filer
SABBY MANAGEMEN
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE